Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by State of Alaska Department of Revenue

State of Alaska Department of Revenue raised its stake in Amedisys, Inc. (NASDAQ:AMED) by 448.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,737 shares of the health services provider’s stock after acquiring an additional 16,955 shares during the period. State of Alaska Department of Revenue’s holdings in Amedisys were worth $1,882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Creative Planning boosted its holdings in shares of Amedisys by 7.4% in the second quarter. Creative Planning now owns 4,295 shares of the health services provider’s stock valued at $394,000 after acquiring an additional 295 shares during the period. CWM LLC raised its position in Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after purchasing an additional 277 shares during the last quarter. Inspire Investing LLC boosted its stake in Amedisys by 11.2% during the 3rd quarter. Inspire Investing LLC now owns 4,250 shares of the health services provider’s stock worth $410,000 after purchasing an additional 428 shares during the period. Exchange Traded Concepts LLC grew its position in Amedisys by 6.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,508 shares of the health services provider’s stock worth $725,000 after purchasing an additional 450 shares during the last quarter. Finally, Signaturefd LLC increased its stake in Amedisys by 20.9% in the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 236 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Price Performance

Shares of AMED opened at $92.52 on Wednesday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The firm has a 50-day simple moving average of $89.66 and a 200-day simple moving average of $93.69. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of 36.71, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.